隽泰控股有限公司2025年报

年報2025ANNUAL REPORT Financial Highlights FINANCIAL AND OPERATING RESULTSHIGHLIGHTS Thefollowing table sets forth certain financial information ofAMCOUnited Holding Limited(the“Company”)and its subsidiaries(collectively, the “Group”) as of the date for the years indicated: Notes: 1.Current ratio is calculated by dividing current assets by current liabilities.2.Totaldebt to total assets ratio is calculated by dividing the totalindebtedness by total assets.3.Return on total assets is calculated by dividing the profit/(loss) for theyear by total assets.4.Return on sales is calculated by dividing the profit/(loss) for the year byrevenue. 1.2.3.4. DIRECTORS Executive Directors JIA Minghui(Chairman)ZHANG Hengxin(Managing Director) Independent Non-executive Directors AU YEUNG Ming Yin GordonGUO ZhenhuiLi Sisi (Appointed on 14 November 2025) COMPANY SECRETARYChan Lok Yin AUTHORISED REPRESENTATIVES ZHANG HengxinChan Lok Yin PRINCIPAL PLACE OF BUSINESS IN HONG KONG 701104 Unit 1104, Crawford House70 Queen’s Road Central, CentralHong Kong REGISTERED OFFICE Clarendon House2 Church StreetHamilton HM11Bermuda Clarendon House2 Church StreetHamilton HM11Bermuda Corporate Information PRINCIPAL BANKERS Standard Chartered Bank (Hong Kong) LimitedBank of China (Hong Kong) Limited AUDITOR 512151510-1517 CCTH CPA Limited(Appointed on 17 December 2024)Unit 1510-1517, 15/FTower 2, Kowloon Commerce CentreNo. 51 Kwai Cheong Road, Kwai ChungNew Territories, Hong Kong Privatco CPA Limited(Resigned on 17 December 2024)Room 1101, 11/FInternational Plaza20 Sheung Yuet RoadKowloon BayHong Kong Privatco CPA Limited20111101 PRINCIPAL SHARE REGISTRAR AND TRANSFEROFFICE Appleby Global Corporate Services (Bermuda)LimitedCanon's Court, 22 Victoria Street,PO Box HM 1179, Hamilton HM EXBermuda Canon’s Court, 22 Victoria StreetPO Box HM 1179, Hamilton HM EXBermuda HONG KONG BRANCH SHARE REGISTRAR ANDTRANSFER OFFICE 1617 TRICOR INVESTOR SERVICES LIMITED17/F, Far East Finance Centre16 Harcourt RoadHong Kong WEBSITE www.amco-united.com www.amco-united.com Chairman’s Statement Despitethe Year 2025 has marked a year of great challenge facinghigh level of uncertainty of the economy as well as the volatile financialmarket in Hong Kong and globally, we made efforts to initiate and boostour momentum of growth by facilitating business development of therespective business segments during the year. The total revenue of theGroup increased HK$30.6 million or 81.0%, from HK$37.8 million lastyear to HK$68.4 million for the year ended 31 December 2025. Suchincrease was mainly attributable to the increase in revenue from sale ofmedical products as the Group expand the product portfolio to include awider range of medical devices, such as surgical instruments (both activeand passive), orthopedic tools, imaging equipment, diagnostic devices,and sterilization products during the year. 37,800,00030,600,00081.0%68,400,000 Tocope with the challenge of fluctuating sales orders,the Groupcontinuesto deploy business strategies focused on streamliningandoutsourcing processes,enforcing stringent cost controls,andensuring efficient resource utilisation to sustain long-term competitiveadvantages.In recent years,the Group has successfully expanded itsproductportfolio within the Medical Devices Business to include awider range of offerings, such as surgical instruments (both active andpassive), orthopedic tools, imaging equipment, diagnostic devices, andsterilization products. As a result of this proactive diversification, salesdemand increased notably from 2024 to 2025, reflecting the tangibleoutcomes of the Group’s ongoing efforts to actively explore and identifypotentialbusiness opportunities,broaden its customer base,andultimately enhance income streams within this segment. Meanwhile,the Group’s Plastic Moulding Business,which has beengradually downsized in recent years, continued to contribute minimalrevenue, with its business scale remaining stable throughout the year. TheGroup’s business in the provision of money lending(“MoneyLending Business”) has generated stable income to the Group in 2025.The Group has recorded a segment profit for its business of investmentinsecurities(“Securities Investment”)in the current year.The Groupwill closely monitor and appraise the performance of this business andcautiously assess the investment portfolio from time to time. Chairman’s Statement PROSPECTS Amidthe complex global landscape of 2026–shaped by ongoingeconomicrecalibration and persistent financial market volatility–theGroup remains steadfast in its commitment to capitalise on emergingtailwinds. Notably, the Medical Devices Business stands to benefit from aconfluence of positive catalysts. Heightened global awareness of personalhealth and well-being continues to drive consumer and institutional focustoward advanced medical solutions. Concurrently, while we express ourprofound regret over the recent geopolitical tensions and conflicts that